Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Curr Opin Hematol. 2019 Nov;26(6):392–398. doi: 10.1097/MOH.0000000000000531

Figure 2:

Figure 2:

Proportion of patients maintaining no evidence of disease activity (NEDA) status over time under different treatment strategies. Points connected by a line represent longitudinal observations in the same study.

Reproduced with permission of Multiple sclerosis, 2017;23(2):201–4.